Pilot Study of Non-invasive Measurement of PD-L1 Levels With Positron Emission Tomography (PET) in Head and Neck Malignancies and Intracranial Metastases
Latest Information Update: 21 Feb 2024
At a glance
- Drugs BMS 986192 (Primary)
- Indications Brain metastases; Breast cancer; Head and neck cancer; Lung cancer; Squamous cell cancer
- Focus Diagnostic use
- 13 Feb 2024 Status changed from recruiting to discontinued.
- 24 Feb 2023 Status changed from not yet recruiting to recruiting.
- 10 Oct 2022 Planned initiation date changed from 1 Aug 2022 to 1 Nov 2022.